Inda zan Sayi Lorcaserin da matsakaita?

Kuna iya yin sayan lorcaserin a shagunan yanar gizo. Ana samun foda a cikin yawa don masu bincike da manazarta. Lokacin da burin ku ya rasa ƙarin fam saboda kiba, zaku iya bincika lorcaserin don siyarwa akan layi. Koyaya, zaku iya buƙatar takardar sayan magani sakamakon tsayayyun jagororin da FDA.
Idan kuna neman lorcaserin ko tsaka-tsakinsu, yakamata ku shiga tare da CMOAPI don ingantaccen kayan samfuran. Ma'aikatanmu sun sami tabbacin inganci.

( 1 ) ↗

Source Amintacce

PubMed Central

Babban mutunta bayanai daga Cibiyoyin Lafiya na Ƙasa
Je zuwa tushen

Lorcaserin-Bayani-01 Lorcaserin-Bayani-02 Lorcaserin-Bayani-03

Tambayoyin Lorcaserin

Ta yaya zan ɗauki belviq don kyakkyawan sakamako?

Haɗa kwamfutar hannu da aka faɗaɗa gaba ɗaya kuma kada a murƙushe, tauna, ko karya shi. Kuna iya ɗaukar Belviq tare da ko ba tare da abinci ba. Ya kamata ku rasa aƙalla 5% na nauyin farawa lokacin farkon makonni 12 na farko ɗaukar Belviq da cin abinci maras kalori.

Nawa nauyi za ku iya rasa tare da belviq?

Lorcaserin, wanda aka yi amfani dashi haɗe tare da abinci da motsa jiki, yana haifar da ƙarancin nauyi na kusan 12.9 lb (5.8 kg) idan aka kwatanta da 5.6 lb (2.5 kg) tare da placebo.

Har yaushe za ku ɗauki belviq?

Kuna iya ɗaukar Belviq tare da ko ba tare da abinci ba. Ya kamata ku rasa aƙalla 5% na nauyin farawa lokacin farkon makonni 12 na farko na shan Belviq da cin abinci maras kalori. Kira likitan ku idan ba ku rasa aƙalla 5% na nauyin farawa bayan shan magani don makonni 12.

Yaya belviq ya sa ku ji?

Belviq an san shi azaman mai karɓar mai karɓa na serotonin 2C, wanda ke nufin yana kunna takamaiman sassan kwakwalwar ku wanda zai sa ku ji daɗi. Hungerarancin yunwa yana haifar da ƙarancin cin abinci, wanda ke haifar da asarar nauyi.

( 2 ) ↗

Source Amintacce

PubMed Central

Babban mutunta bayanai daga Cibiyoyin Lafiya na Ƙasa
Je zuwa tushen

Menene sakamakon tasirin lorcaserin?

Illolin da ke tattare da Belviq sun hada da: karancin suga (hypoglycemia), matsalolin tunani, saurin bugawar zuciya, ciwon kai, jiri, jiri, jin kasala, kasala,

Shin zaku iya shan giya yayin shan belviq?

Shin dukkan kwayoyi masu asarar nauyi suna hulɗa da barasa? Ba duk ƙwayoyin asara ke da ma'amala da ƙwayoyi tare da barasa ba; misali, lorcaserin (Belviq, Belviq XR) da jerin sunayen (Alli, Xenical) ba sa lissafin hulɗar miyagun ƙwayoyi a cikin lakabin samfurin su.

Shin belviq zai iya haifar da kiba?

Sakamakon siriri. Mutanen da ke shan magani tsawon shekara guda na iya tsammanin rasa kashi 3 zuwa 3.7 bisa ɗari na nauyinsu, kuma suna iya dawo da nauyi, bincike ya ba da shawara. A cikin gwaji daya, marasa lafiya da ke shan Belviq sun rasa kashi 5 na nauyin jikinsu bayan watanni 12, amma sun sami kashi 25 cikin ɗari a ƙarshen shekara ta biyu.

Wanne ya fi kwanciya ko belviq?

Belviq da Contrave suna cikin azuzuwan magunguna daban-daban. Belviq shine mai karɓa mai karɓa na serotonin 2C kuma Contrave haɗuwa ne da mai maganin opioid da antidepressant.

Shin belviq yana aiki da gaske?

Mutanen da ke shan magani tsawon shekara guda na iya tsammanin rasa kashi 3 zuwa 3.7 cikin ɗari na nauyinsu

Shin belviq yayi kama da Phentermine?

Belviq (lorcaserin hydrochloride) da Adipex-P (phentermine) ana amfani dasu don kula da nauyi a cikin marasa lafiya masu kiba ban da abinci da motsa jiki. Ana amfani da Belviq don gudanar da nauyin nauyi na yau da kullun.

Shin belviq ya daina aiki?

Hukumar Abinci da Magunguna ta Amurka (FDA) ta nemi mai kera Belviq, Belviq XR (lorcaserin) da son ransa ya janye magungunan rage nauyi daga kasuwar Amurka.

( 3 ) ↗

Source Amintacce

PubMed Central

Babban mutunta bayanai daga Cibiyoyin Lafiya na Ƙasa
Je zuwa tushen

References

  1. Taylor, J., Dietrich, E., da Powell, J. (2013). Lorcaserin don Gudanar da nauyi. Ciwon sukari, Ciwon Cutar Magani, da Kiba.
  2. Hoy, SM (2013). Lorcaserin: Nazarin Amfani da shi a cikin Kulawar Weight. Kwayoyi.
  3. Hess, R., da Gicciye, LB (2013). Tsaro da Ingancin Lorcaserin a cikin Gudanar da Kiba. Postgraduate Medicine.
  4. Brashier, DB, Sharma, AK, Dahiya, N., da Singh, SK (2014). Lorcaserin: Magungunan Antiobesity na Novel. Jaridar Pharmacology & Pharmacotherapeutics.
  5. Chan, EW et al. (2013). Inganci da Tsaro na Lorcaserin a cikin Manya Manya: Meta-Analysis na 1-shekara Randomized Control Trials (RCTs) da Rarraba Nazari akan Short-Term RCTs. Bayanan kiba.
  6. Nigro, SC, Luon, D., da Baker, WL (2013). Lorcaserin: Wani Labari na Serotonin 2C Agonist don Kula da Kiba. Binciken Nazarin Lafiya na Yanzu da Ra'ayi.